Virta Health Revenue, Valuation, Funding & Investors
Virta Health is valued at $2B as of April 2021, a 12.5x multiple on its last reported $160M revenue.
Last Virta Health valuation
$2B
Series E · Apr 2021
Last Virta Health funding round
$133M
Series E · Apr 2021
Virta Health revenue
$160M
Series E · Apr 2021
Key investors in Virta Health
Venrock
Caffeinated Capital
Creandum
Obvious Ventures
Playground Global
SciFi VC
About Virta Health
Virta Health is a San Francisco-based digital health company that provides a telehealth platform to reverse type 2 diabetes and restore metabolic health through personalized nutrition, coaching, and remote monitoring, without medication or surgery. It contracts with employers, health plans, and government organizations, serving clients such as Purdue University, US Foods, and Activision-Blizzard across all U.S. states. Virta reports that a majority of patients reduce or eliminate insulin use within a year of starting the program.
Founded
2014
HQ
United StatesWebsite
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Revenue
$160M (Apr 2021)
Valuation
$2B (Apr 2021)
Virta Health Valuation
Virta Health is currently valued at $2B, based on its Series E in April 2021.
The $133M round was led by Tiger Global.
Virta Health's valuation has grown 1.8x from $1.1B at its Series C in January 2020 to $2B in April 2021, across 3 priced rounds.
Virta Health valuation by funding round
Revenue multiple| Date | Stage | Valuation | Revenue Multiple |
|---|---|---|---|
| Apr 2021 | Series E | $2B | 12.5x |
| Dec 2020 | Series D | $1.1B | 6.9x |
| Jan 2020 | Series C | $1.1B | 6.9x |
Virta Health Revenue
Virta Health's latest recorded revenue is $160M, as of its Series E in April 2021. At a $2B valuation, that implies a 12.5x revenue multiple.
Revenue moved from $160M in January 2020 to $160M in April 2021, while the revenue multiple moved from 6.9x to 12.5x.
Virta Health revenue by funding round
| Date | Revenue * | Valuation | Revenue Multiple | Stage |
|---|---|---|---|---|
| Apr 2021 | $160M | $2B | 12.5x | Series E |
| Dec 2020 | $160M | $1.1B | 6.9x | Series D |
| Jan 2020 | $160M | $1.1B | 6.9x | Series C |
* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.
Virta Health Funding History
Virta Health has raised a total of $373M across 5 funding rounds.
Virta Health's first fundraising round was a $37M Series A in March 2017. The most recent completed round was a $133M Series E in April 2021.
Virta Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Apr 2021 | Series E | Tiger Global (lead) | $133M | $2B | Virta Health, a San Francisco-based digital health company, provides a telehealth platform offering clinically proven therapies to reverse type 2 diabetes and restore metabolic health through personalized ketogenic diets, coaching, and remote monitoring. The company serves employers, health plans, and government organizations, with a client base of about 100 entities including Purdue University, US Foods, Nielsen, and Activision-Blizzard, reaching users across all U.S. states. Virta claims 94% of patients eliminated or reduced insulin usage after one year, positioning its interventions to save payers around $5,000 per patient annually amid the high costs of diabetes care, estimated at $327 billion in the U.S. in 2017. On April 19, 2021, Virta Health raised $133 million in a Series E funding round led by Tiger Global Management, achieving a post-money valuation of $2 billion—nearly double the $1.1 billion valuation from its prior $65 million Series D in December 2020. This brought cumulative funding to approximately $366-402 million across five rounds, with prior investors including Redmile Group and Venrock. The round propelled Virta into unicorn status and reflects surging demand, with nearly 200% year-over-year growth. Proceeds from the Series E will expand patient programs, accelerate clinical research, scale digital care infrastructure, support product innovation, and meet commercial demand from employers and health plans seeking diabetes reversal solutions. Executives highlight a shift from traditional medication-heavy diabetes management toward reversal approaches, amid a global digital health market projected to reach $640 billion by 2026 at a 28.5% CAGR, driven by chronic disease prevalence and pandemic-accelerated telehealth adoption. |
| Dec 2020 | Series D | Sequoia Capital (lead); Saya Bio; Caffeinated Capital | $65M | $1.1B | Virta Health is a San Francisco-based digital health company dedicated to reversing type 2 diabetes and other chronic metabolic conditions without medications or surgery, using a clinician-prescribed, continuous remote care platform that combines personalized nutrition, coaching, and behavioral support. The company's treatment has demonstrated clinical success, with sustained improvements in blood sugar levels, weight loss, blood pressure, inflammation, liver function, and BMI, attracting endorsements from over 100 healthcare payers including employers, health plans, and government groups like the State Employees’ Insurance Board of Alabama. On December 2, 2020, Virta Health raised $65 million in a Series D funding round led by Sequoia Capital Global Equities, with participation from Caffeinated Capital—note that Saya Bio is not mentioned in sources for this round. This investment brought the company's total funding to over $230 million and valued Virta at $1.1 billion post-money, achieving unicorn status. The capital was earmarked to accelerate sales and marketing, scale the Continuous Remote Care platform, expand research into non-pharmaceutical therapies for metabolic conditions, and meet surging demand amid the COVID-19 pandemic. Virta's approach differentiates through its risk-sharing model for enterprises, putting 100% of fees at risk and claiming over 70% reduction in medical prescription costs in the first year. The company targets the massive U.S. metabolic crisis, where diabetes and prediabetes affect about 122 million adults and contribute to over $3 trillion in annual healthcare spend, positioning itself as a cost-saving alternative with potential savings of $5,000 per patient per year for payers. This Series D followed prior raises and preceded a Series E in 2021 led by Tiger Global at a $2 billion valuation with $133 million raised, reflecting rapid growth. Virta's traction includes serving clients across all U.S. states and clinical outcomes like over 90% of patients reducing or eliminating insulin use within a year. |
| Jan 2020 | Series C | Caffeinated Capital (lead); Creandum; Obvious Ventures; SciFi VC; StartUp Health; Tim Kendall; Venrock; Playground Global; Base Partners | $93M | $1.1B | Virta Health is a healthcare company focused on reversing type 2 diabetes without medications or surgery through its provider-led virtual care delivery platform, Continuous Remote Care. The company raised $65 million in its Series D funding round in December 2020, led by Sequoia Capital Global Equities with participation from Caffeinated Capital, bringing total funding to over $230 million and valuing the company at $1.1 billion. The Series D proceeds were allocated to accelerate growth, scale the care platform, expand research into non-pharmaceutical therapies for other metabolic conditions, and meet rising demand for diabetes reversal treatments. Virta serves enterprises with a risk-sharing model, putting 100% of fees at risk and claiming over 70% reduction in medical prescription costs in the first year. The treatment combines medical and behavioral support to transform lives of those with type 2 diabetes and related conditions. |
| Apr 2018 | Series B | Venrock (lead); Creandum; Obvious Ventures; SciFi VC; Playground Global; Founders Fund; Caffeinated Capital | $45M | - | Virta Health, a San Francisco-based company, provides a clinically-proven, digitally-delivered treatment to reverse type 2 diabetes and other chronic metabolic diseases like obesity, hypertension, and cardiovascular risk without medications or surgery. The treatment uses a technology platform for continuous remote care by licensed physicians across all 50 U.S. states, achieving 60% diabetes reversal and 83% patient retention after one year in clinical trials, with similar outcomes in thousands of commercial patients. The company has partnerships with employers and insurance companies, estimating average payer savings of $9,600 per patient over 24 months compared to conventional care. On April 4, 2018, Virta Health raised $45 million in a Series B funding round, led by Venrock with participation from existing investors including Obvious Ventures, Creandum, Caffeinated Capital, and SciFi VC (Max Levchin), plus new investors Founders Fund and Playground Global. This brought total equity funding to $75 million (or $82 million per one source). Funds will accelerate growth, improve outcomes, scale the treatment, invest in machine learning, AI, product, engineering, data science, and clinical teams to serve millions suffering from reversible chronic diseases. At the time, Virta had nearly 100 employees, mainly in San Francisco, and aimed to address a significant portion of the $3 trillion annual U.S. healthcare spend on chronic metabolic diseases. |
| Mar 2017 | Series A | Venrock (lead) | $37M | - | Virta Health is a telehealth platform that delivers clinically proven treatments to reverse Type 2 diabetes without medications or surgery. The company's approach combines personalized nutrition plans with a smartphone app and access to health coaches, focusing on carbohydrate restriction to control blood sugar levels. Virta's model places 100% of fees at risk for enterprises and claims to reduce medical prescription costs by more than 70% in the first year. The company went on to achieve unicorn status in April 2021 with a $2 billion valuation following a $133 million Series E round led by Tiger Global Management. By December 2023, Virta employed 443 people and had built a client base of approximately 100 organizations spanning employers, health plans, and government groups across all U.S. states. Co-founder and CEO Sami Inkinen has positioned the company as transforming the standard of care for chronic disease treatment through machine learning, AI, and continuous remote care delivery. |
Who has invested in Virta Health?
13 investors have backed Virta Health across its funding rounds, including Venrock, Caffeinated Capital, Creandum, Obvious Ventures, Playground Global and SciFi VC.
Lead investors include Tiger Global, Sequoia Capital, Caffeinated Capital and Venrock.
Virta Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| San Francisco, CA | 3 | Lead | Mar 2017 | |
| San Francisco, CA | 3 | Lead | Apr 2018 | |
 Stockholm | 2 | Participant | Apr 2018 | |
| San Francisco, CA | 2 | Participant | Apr 2018 | |
| San Francisco, CA | 2 | Participant | Apr 2018 | |
| San Francisco, CA | 2 | Participant | Apr 2018 | |
| New York City, NY | 1 | Participant | Jan 2020 | |
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Tim Kendall | San Francisco, CA | 1 | Participant | Jan 2020 |
| California City, CA | 1 | Participant | Dec 2020 | |
| San Francisco, CA | 1 | Lead | Dec 2020 | |
| San Francisco, CA | 1 | Participant | Apr 2018 | |
This data is available for Pro users. Sign up to see all 13 Virta Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialVirta Health Competitors
Virta Health competitors include listed companies like Compass Pathways and Alignment Healthcare, and private ones like NuCom Group, Cult.fit, MindMaze and Pristyn Care.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
 United Kingdom | Publicly listed | - | ($293M) | $2.1B | - | |
 Munich | Private | - | - | $2.2B | - | |
| United States | Publicly listed | $3.9B | $45M | $1.8B | 0.3x | |
 Bangalore | Private | $74M | - | $1.5B | - | |
 Lausanne | Private | $8M | - | $1.5B | 187.5x | |
| Gurgaon | Private | $64M | - | $1.4B | - |
Virta Health Public Comps
Virta Health is still privately-owned, but its public comps include Compass Pathways, Alignment Healthcare, Helus Pharma, Sphere, Nyxoah, Oneview Healthcare, Kooth, Saluda Medical and DarioHealth.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($293M) | - | - | (5.8x) | (8.4x) | |||
| $3.9B | $45M | 0.4x | 0.3x | 31.6x | 10.0x | |||
| - | ($153M) | - | - | (5.4x) | (4.8x) | |||
| $70M | $6M | 14.3x | 6.9x | 156.3x | 103.0x | |||
| $12M | ($97M) | 9.5x | 3.2x | (1.1x) | (1.4x) | |||
| $14M | ($12M) | 7.1x | 7.1x | (8.2x) | (11.3x) | |||
| $85M | $13M | 0.7x | 0.7x | 4.6x | 4.3x | |||
This data is available for Pro users. Sign up to see all Virta Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Virta Health
| When was Virta Health founded? | Virta Health was founded in 2014. |
| Where is Virta Health headquartered? | Virta Health is headquartered in United States. |
| Is Virta Health publicly listed? | No, Virta Health is a private, VC-backed company. |
| What is Virta Health's valuation? | Virta Health was last valued at $2B in its Series E in April 2021. |
| How much funding has Virta Health raised? | Virta Health has raised $373M across 5 funding rounds. |
| What was Virta Health's last funding round? | Virta Health's last funding round was a $133M Series E in April 2021, led by Tiger Global. |
| Who are Virta Health's investors? | Virta Health's investors include Venrock, Caffeinated Capital, Creandum, Obvious Ventures, SciFi VC, Playground Global, StartUp Health, Tim Kendall, Saya Bio, Sequoia Capital and 3 others. |
| What is Virta Health's revenue? | Virta Health's latest recorded revenue is $160M (April 2021). |
| What is Virta Health's revenue multiple? | Virta Health's latest valuation implies a 12.5x revenue multiple ($2B valuation on $160M of revenue). |
| Which companies are comparable to Virta Health? | Companies comparable to Virta Health include Compass Pathways, NuCom Group, Alignment Healthcare, Cult.fit, MindMaze and Pristyn Care. |
See companies similar to Virta Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.